Evinacumab placebo Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 2: 1

Top Sponsors

Regeneron Pharmaceuticals1

Indications

Diabetic Kidney Disease (DKD)1
Diabetes1

Huntsville, Alabama1 trial

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Apogee Clinical Research, LLC

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.